标题
Characterization of zolbetuximab in pancreatic cancer models
作者
关键词
-
出版物
OncoImmunology
Volume 8, Issue 1, Pages e1523096
出版商
Informa UK Limited
发表日期
2018-11-10
DOI
10.1080/2162402x.2018.1523096
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer
- (2018) Ugur Sahin et al. EUROPEAN JOURNAL OF CANCER
- Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
- (2017) Margaret A. Tempero et al. Journal of the National Comprehensive Cancer Network
- Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial
- (2017) Gary Middleton et al. LANCET ONCOLOGY
- Modulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer Therapy
- (2017) Christian Kellner et al. TRANSFUSION MEDICINE AND HEMOTHERAPY
- Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
- (2016) J. Naidoo et al. ANNALS OF ONCOLOGY
- History of chronic comorbidity and risk of chemotherapy-induced febrile neutropenia in cancer patients not receiving G-CSF prophylaxis
- (2014) C. Chao et al. ANNALS OF ONCOLOGY
- EGFR as a Potential Target for the Treatment of Pancreatic Cancer: Dilemma and Controversies
- (2014) Reza Nedaeinia et al. CURRENT DRUG TARGETS
- Tumor antigen-targeting monoclonal antibody-based immunotherapy: Orchestrating combined strategies for the development of long-term antitumor immunity
- (2014) Henri-Alexandre Michaud et al. OncoImmunology
- Sorafenib does not improve efficacy of chemotherapy in advanced pancreatic cancer: A GISCAD randomized phase II study
- (2013) Stefano Cascinu et al. DIGESTIVE AND LIVER DISEASE
- Claudin 18.2 is a target for IMAB362 antibody in pancreatic neoplasms
- (2013) Stefan Wöll et al. INTERNATIONAL JOURNAL OF CANCER
- Claudin-18 Is an Early-Stage Marker of Pancreatic Carcinogenesis
- (2011) Mariko Tanaka et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Immunohistochemical analysis of claudin expression in pancreatic cystic tumors
- (2011) Park ONCOLOGY REPORTS
- Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
- (2010) Hedy Lee Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205
- (2010) Philip A. Philip et al. JOURNAL OF CLINICAL ONCOLOGY
- Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors
- (2010) M. de Weers et al. JOURNAL OF IMMUNOLOGY
- New Markers of Pancreatic Cancer Identified Through Differential Gene Expression Analyses: Claudin 18 and Annexin A8
- (2009) Zarir E. Karanjawala et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Claudin-18 Splice Variant 2 Is a Pan-Cancer Target Suitable for Therapeutic Antibody Development
- (2008) U. Sahin et al. CLINICAL CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started